DOI: 10.1039/d6md00415f ISSN: 2632-8682
5-Arylidene-3-aryl-imidazol-4-ones as dual VEGFR-2/c-Met inhibitors: design, synthesis, and anticancer evaluation
Hend E. Elshafey, Mostafa M. Elbadawi, Marwa Balaha, Abeer H. A. Abdelhafiz, Tarfah Al-Warhi, Mahmoud A. El Hassab, Viviana di Giacomo, Abdelrahman Hamdi, Ahmed I. KhodairThe results highlighted 12a and 12c as promising dual VEGFR-2/c-Met inhibitors with potent anticancer activity.